UTI HEALTHCARE FUND

Sectoral – Healthcare | (Erstwhile UTI Pharma & Healthcare Fund)
An open ended equity scheme investing in the Healthcare Services Sector. | Data as on 31 October 2021

Investment Objective
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equities and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Inception Date
28th June, 1999
Fund Manager
Mr. V Srivatsa - B.Com., ACA, CWA, PGDM (IIM-I)
Managing the scheme since Mar-2017
Fund AUM
Fund size monthly average : 863.55 Crore
Closing AUM : 827.96 Crore
High/Low NAV in the month
High Growth Option : 173.6246
Low Growth Option : 161.8430
Total expense ratio (%)
Regular : 2.31
Direct : 1.25
Minimum Investment Amount
Growth, IDCW: 5,000/-
Plans/Options (Regular / Direct)
Growth option IDCW option with Payout and Reinvestment
No. of Unit Holding Accounts 52,428
Market Capitalisation (%)
Large
Mid
Small
Fund
55
20
25
Benchmark
62
25
13
Load Structure
Entry Load : Nil
Exit Load : < 30 days – 1%;≥ 30 days – Nil
NAV per unit as on 31st October, 2021
Regular Growth Option 162.9783
Regular IDCW Option 125.9595
Direct Growth Option 176.7825
Direct IDCW Option 136.6411
Benchmark Index
S&P BSE Healthcare
SIP/SWP/STRIP
Digital Factsheet - Checkbox Image
Fund Size 863.55 Crore (Monthly Average as on 31/10/2021)
Overweight (Top 5)
% of Nav
Underweight (Top 5)
% of Nav
Eris Lifesciences Ltd
4.13
Sun Pharmaceuticals Industries Ltd.
-4.45
Aurobindo Pharma Ltd.
3.64
Divis Laboratories Ltd.
-4.09
Ajanta Pharma Ltd.
3.28
Apollo Hospitals Enterprise Ltd.
-3.50
FDC Ltd.
2.88
Laurus Labs Ltd.
-2.51
Fortis Healthcare Ltd.
2.56
Dr. Lal Pathlabs Ltd.
-1.91
UTI Healthcare Fund (Formerly known as UTI Pharma & Healthcare Fund) IDCW Declared
Year
IDCW 
Per unt
NAV (Cum Div )
Face Value (per unit)
NAV Date
Record Date
2006
25%
2.50
21.34
10.00
10-01-2006
17-01-2006
2008
15%
1.50
20.91
10.00
26-08-2008
02-09-2008
2010
17%
1.70
32.65
10.00
28-10-2010
04-11-2010

The scheme IDCW details under regular plan.
Disclaimer:Pursuant to payment of Dividend/Bonus, the Nav of the income distribution cum capital withdrawal options of the schemes would fall to the extent of payout and statutory levy (if applicable)

Equity
% of NAV
Dr Reddy's Laboratories Ltd.
10.01
Sun Pharmaceuticals Industries Ltd.
8.86
Cipla Ltd.
7.95
Aurobindo Pharma Ltd.
6.65
Divis Laboratories Ltd.
6.10
Fortis Healthcare Ltd.
4.54
Lupin Ltd.
4.50
Eris Lifesciences Ltd
4.49
Ajanta Pharma Ltd
4.11
IPCA Laboratories Ltd.
3.26
Apollo Hospitals Enterprise Ltd.
3.16
FDC Ltd.
3.14
J.B.Chemicals & Pharmaceuticals Ltd
2.77
Alembic Pharmaceuticals Ltd.
2.64
Krishna Institute Of Medical Science Ltd
2.63
Narayana Hrudayalaya Ltd
2.61
Cadila Healthcare Ltd.
2.54
Advanced Enzyme Technologies Ltd
2.03
Alkem Laboratories Ltd
1.98
Metropolis Healthcare Ltd
1.02
Poly Medicure Ltd.
1.61
AMI Organics Ltd
1.57
Torrent Pharmaceuticals Ltd.
1.48
Abbott India Ltd.
1.46
Suven Pharmaceuticals Ltd
1.36
Gland Pharma Ltd
1.32
Proctor & Gamble Health Ltd
1.28
Biocon Ltd.
1.16
Windlas Biotec Ltd
0.90
Laurus Labs Ltd.
0.63
Net Current Assets
2.24
TOTAL
100.00
% of top 10 stocks 
60.47
Median Market Cap ( Cr) 
40,192
Weighted Average Market Cap 
56,240
Number of Securities 
30
All figures given are provisional and unaudited.
Quantitative Indicators
Fund
Benchmark
Beta
0.89
1
Standard Deviation (Annual)
17.98%
19.73%
Sharpe ratio
1.13%
Portfolio Turnover Ratio (Annual)
0.48
P/B
6.17
7.45
P/E
38.12
44.85
RoE
16.47
15.99
Fund Performance Vs Benchmark (CAGR) as on 31st October, 2021 Growth of 10000
Period
NAV Growth (%)
S&P BSE
Healthcare (%)
Nifty 50 (%)
NAV Growth 
()
S&P BSE
Healthcare
()
Nifty 50 ()
1 Year
27.98
30.74
53.54
12,798
13,074
15,354
3 Years
23.69
20.14
20.77
18,935
17,349
17,624
5 Years
11.49
9.43
16.85
17,231
15,696
21,794
Since inception*
14.72
14.93
NA
215,509
224,504
NA

Different plans have a different expense structure. The performance details provided herein are of regular plan.
*Compounded annualized Growth Rate.
For performance details of other Schemes managed by the Fund Manager, please refer the respective Scheme sheets as listed Please click here in ‘Fund Manager Summary’. N.A Not Available. No of Schemes Managed by Mr. V Srivatsa is 7.
As TRI data is not available since inception of the scheme, benchmark performance is calculated using composite CAGR of Nifty Pharma. PRI values from 28th June 1999 to 3rd April 2006. TRI Value From 4th April 2006.
The performance of the benchmark is calculated using total return index variant of the benchmark index.

Period
Investment Amount ()
Value- Fund ()
S&P BSE
Healthcare
()
Nifty 50 ()
Yield (%) Fund
Yield (%)
S&P BSE
Healthcare
Yield (%)
Nifty 50
1 Year
120,000
131,290
131,710
144,782
18.08
18.77
40.83
3 Years
360,000
572,386
559,824
541,447
32.67
30.99
28.48
5 Years
600,000
1,024,809
987,417
993,748
21.60
20.06
20.32
7 Years
840,000
1,449,306
1,373,415
1,550,256
15.33
13.82
17.22
10 Years
1,200,000
2,634,753
2,520,248
2,756,869
15.04
14.21
15.89
15 Years
1,800,000
6,454,129
6,421,416
5,492,303
15.53
15.47
13.67
Since inception*
2,030,000
8,459,574
8,549,413
7,436,315
15.16
15.27
13.88

Note: Systematic Investment Plan (SIP) returns are worked out assuming investment of 10,000/- every month at NAV per unit of the scheme as on the first working day for the respective time periods. The loads have not been taken into account.*Since inception for above mentioned schemes is taken for the period December 2004 to October 2021 (Since SIP facility was introduced in November 2004. Past performance may or may not be sustained in future.

*Investors should consult their Mutual Fund Distributor if in doubt about whether the product is suitable for them.

  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities in the Healthcare Service sector

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Riskometer